ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $290,777 | -100.0% | 12,141 | -73.7% | 0.00% | -60.0% |
| Q2 2022 | $651,011,000 | -60.3% | 46,171 | -31.7% | 0.01% | -50.0% |
| Q1 2022 | $1,638,289,000 | -14.5% | 67,642 | -17.6% | 0.01% | -9.1% |
| Q4 2021 | $1,916,615,000 | +27.0% | 82,082 | -9.6% | 0.01% | +10.0% |
| Q3 2021 | $1,508,852,000 | -33.5% | 90,840 | -2.3% | 0.01% | -33.3% |
| Q2 2021 | $2,267,270,000 | -5.0% | 92,959 | +0.5% | 0.02% | -11.8% |
| Q1 2021 | $2,385,881,000 | -19.0% | 92,476 | +67.8% | 0.02% | -34.6% |
| Q4 2020 | $2,945,539,000 | +216.8% | 55,098 | +144.4% | 0.03% | +160.0% |
| Q3 2020 | $929,858,000 | – | 22,542 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |